Products for Research Use Only

BGC201531

CAT: 1410-M23357-06Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1410-M23357-06Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
BGC201531 is a EP4 antagonist for the treatment of acute migraine.
CAS Number
1186532-61-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
496.58
Molecular Formula
C26H28N2O6S
Notes
Research use only, not for human use.
Receptor
EP4

Chemical Information

Bgc-20-1531
CAS Number1186532-61-5
PubChem CID25209437
IUPAC Namesodium [4-[[4-(5-methoxy-2-pyridinyl)phenoxy]methyl]-5-methylfuran-2-carbonyl]-(2-methylphenyl)sulfonylazanide
Molecular FormulaC26H23N2NaO6S
Molecular Weight514.5
Topological Polar Surface Area105
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count8
Rotatable Bond Count8
Heavy Atom Count36
Formal Charge0
Complexity801
SMILES
CC1=CC=CC=C1S(=O)(=O)[N-]C(=O)C2=CC(=C(O2)C)COC3=CC=C(C=C3)C4=NC=C(C=C4)OC.[Na+]
InChI
InChI=1S/C26H24N2O6S.Na/c1-17-6-4-5-7-25(17)35(30,31)28-26(29)24-14-20(18(2)34-24)16-33-21-10-8-19(9-11-21)23-13-12-22(32-3)15-27-23;/h4-15H,16H2,1-3H3,(H,28,29);/q;+1/p-1
InChIKey
TVDHMDXPKGMXRT-UHFFFAOYSA-M
Chemical Structure
2D Structure
2D structure of Bgc-20-1531
CAS: 1186532-61-5
CID: 25209437
Formula: C26H23N2NaO6S
MW: 514.5
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight514.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count8
Rotatable Bond Count8
Exact Mass514.11745191
Monoisotopic Mass514.11745191
Topological Polar Surface Area105 Ų
Heavy Atom Count36
Formal Charge0
Complexity801
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count2
Compound Is CanonicalizedYes